Ensayos clínicos Solicite una Consulta en Mayo Clinic Sedes, viajes & alojamientoInvestigación March 27, 2021 Comparte en: FacebookTwitter A continuación se enumeran ensayos clínicos actuales.67 estudios en Programa de tumores cerebrales (estudios abiertos únicamente). Filtrar esta lista de estudios según la ubicación, el estado del estudio y más. A Study to Compare Stereotactic Radiosurgery to Hippocampal-Avoidant Whole Brain Radiotherapy Rochester, Minn., Jacksonville, Fla. The puropse of this study is to compare stereotactic radiosurgery (SRS) to whole brain radiotherapy (WBRT) in patients with 5 to 15 brain metastases. Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery Rochester, Minn. This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Visual Outcomes in Patients with Neurofibromatosis Type 1 Rochester, Minn. The purpose of this study is to determine visual outcome in patients with neurofibromatosis type 1 (NF1). The study will also correlate visual outcome with the history of optic glioma based on previous MRI imaging and compare visual outcomes in treated and untreated adult NF1 patients with a history of optic glioma. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients Scottsdale/Phoenix, Ariz. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer patients in order to improve quality of life (QOL) in patients receiving clinical care at Mayo Clinic. A Study to Compare Single Fraction Stereotactic Radiosurgery Compared with Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to compare how well single fraction stereotactic radiosurgery works versus fractionated stereotactic radiosurgery in treating patients with cancer that has spread to the brain from other parts of the body and has been removed by surgery. Single fraction stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Fractionated stereotactic radiosurgery delivers multiple, smaller doses of radiation therapy over time. Brain Tumor Induced Immunosuppression Rochester, Minn. The purpose of this study is to determine the presence of immunosuppressive molecules and immunosuppressive leukocytes in brain tumor patients’ blood. Brain Tumor Repository Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of the Mayo Clinic system so that important research questions can be answered. Image-based Mapping of Brain Tumors Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to evaluate the side effects and best dose of CB-839 hydrochloride (CB-839) in combination with radiation therapy and temozolomide in treating participants with IDH-mutated diffuse or anaplastic astrocytoma. CB-839 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or stopping them from spreading. Giving CB-839 with radiation therapy and temozolomide may work better in treating participants with IDH-mutated diffuse astrocytoma or anaplastic astrocytoma. Evaluating the Impact of 18F-DOPA-PET on Radiotherapy Planning for Newly Diagnosed Gliomas Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to use a nutrient called 18F-FDOPA and PET/CT scan to help determine where and how big the tumor is, as well as how aggressive the tumor is. This will help treating physicians to target diseased areas with higher than standard doses of radiation, in order to improve the effectiveness of radiation in this tumor. Numeración de páginas Estudios clínicos AnteriorPágina anterior Ir a página 22 Ir a página 33 Ir a página 44 Ir a página 55 Ir a página 66 SiguientePróxima página Mayo Clinic en Rochester, Minnesota, y Mayo Clinic en Jacksonville, Florida están clasificadas entre los mejores hospitales de neurología y neurocirugía del país durante el período 2020-2021 por U.S. News & World Report. Obtén más información sobre este gran honor Programa de tumores cerebralesPágina inicial del departamentoSeccionesSolicita una cita médicaPanorama generalAnálisis y procedimientosEnfermedades que se tratanMédicosMédicos por ubicación y especialidadGrupos especializadosPericia & clasificacionesSedes, viajes & alojamientoEnsayos clínicosInvestigaciónExperiencia en Mayo Clinic e historias de pacientesCostos & seguro médicoNoticias de Mayo ClinicRecursos para profesionales en Medicina Investigación: todo es por los pacientes SeccionesSolicita una cita médicaPanorama generalAnálisis y procedimientosEnfermedades que se tratanMédicosMédicos por ubicación y especialidadGrupos especializadosPericia & clasificacionesSedes, viajes & alojamientoEnsayos clínicosInvestigaciónExperiencia en Mayo Clinic e historias de pacientesCostos & seguro médicoNoticias de Mayo ClinicRecursos para profesionales en Medicina ORG-20439710 Departamentos y centros Centros y departamentos médicos Programa de tumores cerebrales